drugset / Trial / NCT05999942

A Study to Investigate Lung Deposition of Inhaled Amikacin-loaded Liposomes in Healthy Male Participants

NCT05999942

Phase 1 Completed 6 enrolled Insmed Incorporated
NaSingle-groupOpen-labelTreatment

Summary

The primary purpose of this study is to determine the intra and extra pulmonary deposition and clearance of inhaled amikacin-loaded liposomes by gamma scintigraphy in healthy male participants.

Timeline

Start
2004-06-02
Primary completion
2004-06-29
Completion
2004-06-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Amikacin Small molecule Inhaled

Indications

No indication recorded.